Market Cap: $561.9M
MI
MiMedx Group, Inc.
MDXG
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $561.9M
MiMedx Group: A Strong Surge in Regenerative Medicine MiMedx Group showcases impressive performance in its Q4 earnings report, which reflects a significant upward trajectory driven by robust demand fo…
MiMedx Group Posts Robust Financial Results, Driven by Regenerative Medicine Growth MiMedx Group delivers strong Q4 performance, showcasing a significant year-over-year revenue increase of 15% to $100…
MiMedx Group Reports Strong Q4 Earnings, Highlighting Regenerative Medicine Growth MiMedx Group (NASDAQ: MDXG) reveals a robust financial performance for its fourth quarter of 2026, demonstrating sign…
Mimedx Group Sees Surge in Demand for Flagship Products Amid Strong Financial Results Mimedx Group reports a significant uptick in demand for its flagship regenerative medicine products, indicating a…
Mimedx Group Capitalizes on Market Demand for Regenerative Medicine Mimedx Group, a leader in regenerative medicine, continues to strengthen its foothold in the industry, driven by rising demand for i…
Mimedx Group: Capitalizing on Market Demand for Regenerative Medicine Mimedx Group, a leader in regenerative medicine, continues to leverage its innovative product portfolio to meet the growing demand…
Mimedx Group's Commitment to Advancing Regenerative Medicine Mimedx Group, a leader in regenerative medicine, continues to push the boundaries of healing through its innovative biomaterial products. T…
Mimedx Group Advances in Regenerative Medicine with New FDA Approval Mimedx Group, a leader in regenerative medicine, receives a significant boost as it announces FDA approval for its latest product a…
Mimedx Group Advances in Regenerative Medicine with Innovative Product Launch Mimedx Group, a leader in the field of regenerative medicine, unveils its latest product aimed at enhancing wound care man…
Confidence in Innovation: Insider Purchases Signal Faith in MiMedx Group's Future In a noteworthy development for MiMedx Group (MDXG), recent insider transactions reflect a strong belief in the compan…
Insider Confidence Boosts MiMedx Group's Market Positioning In a recent development that underscores a growing confidence in MiMedx Group's future, several board members have made notable insider purc…
MiMedx Group’s Growth in Regenerative Medicine Amid Challenges MiMedx Group Inc. reports a robust first quarter for 2025, with net sales reaching $88.2 million, marking a 4.1% increase from $84.7 mill…
MiMedx Group's Strategic Innovations Drive Growth in Regenerative Medicine MiMedx Group Inc., a prominent player in the regenerative biomaterials sector, demonstrates resilience in its first-quarter r…
MiMedx Group's Strong Performance Amid Competitive Pressures in Regenerative Medicine MiMedx Group Inc., a frontrunner in regenerative biomaterial products, showcases resilience in its recent quarterl…